Nolan Gartin
Family Medicine · Excelsior Springs, MONPI 1437564721
Payments from drug & device makers
Across 123 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$335
- Novo Nordisk$306
- AstraZeneca$250
- Teva Pharmaceuticals USA, Inc.$181
- Vanda Pharmaceuticals Inc.$153
- Amgen$149
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,402100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $335 |
| Novo Nordisk | 18 | $306 |
| AstraZeneca | 15 | $250 |
| Teva Pharmaceuticals USA, Inc. | 10 | $181 |
| Vanda Pharmaceuticals Inc. | 5 | $153 |
| Amgen | 8 | $149 |
| GSK | 5 | $117 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $115 |
| AbbVie | 4 | $102 |
| Lilly USA, LLC | 6 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $88 |
| Phathom Pharmaceuticals, Inc. | 4 | $75 |
| Astellas Pharma US Inc | 2 | $60 |
| Lundbeck LLC | 3 | $59 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| Mylan Specialty L.p. | 3 | $50 |
| Boehringer Ingelheim | 2 | $28 |
| Eisai Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| Organon | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Nevro Corp. | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
| Pfizer | 1 | $15 |
| Electromed, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Boston Scientific | 1 | $13 |
How this compares
$2,402 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $27,585 |
| EliquisApixaban | 23 | $26,139 |
| MounjaroTirzepatide | 21 | $25,493 |
| OzempicSemaglutide | 20 | $25,363 |
| FarxigaDapagliflozin Propanediol | 24 | $17,744 |
| JardianceEmpagliflozin | 14 | $13,957 |
| JanuviaSitagliptin Phosphate | 12 | $13,563 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $8,588 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,370 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 85 | $2,175 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 87 | $2,154 |
| Gabapentin | 80 | $1,950 |
| Tizanidine Hcl | 21 | $1,287 |
| Atorvastatin Calcium | 131 | $1,124 |
| Levothyroxine Sodium | 91 | $704 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $117 | $36,17351 claims |
| PfizerEliquis | $15 | $26,13923 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $250 | $26,11437 claims |
| Lilly USA, LLCMounjaro | $98 | $25,49321 claims |
| Novo NordiskOzempic | $306 | $25,36320 claims |
| Boehringer IngelheimJardiance | $28 | $13,95714 claims |
| MerckJanuvia | $14 | $13,56312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Excelsior Springs
- James LasalleExcelsior Springs$130K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.